Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

LUCARA ANNOUNCES $10 MILLION DRAW FROM LIMITED SHAREHOLDER STANDBY UNDERTAKING AND RECENT NOTABLE DIAMOND RECOVERIES

(LUC) VANCOUVER, BC, Aug. 29, 2025 /PRNewswire/ - (TSX: LUC) (BSE: LUC) (Nasdaq FNGM: LUC) PDF Version Lucara Diamond Corp. ("Lucara" or the "Company") announces the draw down of $10.0 million of t...

How does this financing arrangement and its terms compare to similar financing structures used by peer junior diamond explorers, and what dilution or covenant risks might arise? What does the recent notable diamond recoveries suggest about future production volumes and revenue potential? How will the $10 million draw down from the standby undertaking affect Lucara’s cash position and liquidity runway?
Symbol: LUC
Financing
17 days ago
Read more prnewswire

Avista Makes Annual Price Adjustment Requests in Washington

(AVST) Overall changes would be effective November 1, 2025 for electric and natural gas customers Overall changes would be effective November 1, 2025 for electric and natural gas customers

How does Avista's requested price increase compare to recent adjustments by other utility peers in the region, and what impact might this have on its relative valuation? What is the likelihood that Washington regulators will approve the requested price changes, and are there any known objections or legal challenges? How will the November 1 2025 rate adjustments affect Avista's projected revenue and earnings per share for FY2025‑26?
Symbol: AVST
Regulation
18 days ago
Read more globenewswire

EHC Investors Have Opportunity to Lead Encompass Health Corporation Securities Fraud Lawsuit

(NYSE:EHC) NEW YORK, Aug. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Enc...

What is the expected timeline for resolution and how might it influence investor sentiment? What potential financial penalties and liabilities could arise from the securities fraud claims? How will the lawsuit affect EHC's short‑term stock volatility?
Symbol: EHC
Lawsuits
18 days ago
Read more prnewswire

ALZHEIMER'S ASSOCIATION WELCOMES FDA ACTION APPROVING LEQEMBI WEEKLY SUBCUTANEOUS MAINTENANCE DOSING

(NASDAQ:BIIB) CHICAGO, Aug. 29, 2025 /PRNewswire/ -- The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) action to approve weekly subcutaneous maintenance dosing of...

What are the potential risks related to insurance coverage, pricing, and supply chain that could influence the long‑term profitability of Leqembi after this approval? What impact will this new dosing regimen have on Biogen's revenue forecasts and market share compared to competing Alzheimer’s therapies such as Aduhelm and donanemab? How will the FDA approval of weekly subcutaneous dosing for Leqembi affect Biogen's (BIIB) stock price and trading volume in the short term?
Symbol: BIIB
Fda approval
18 days ago
Read more prnewswire

US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease

(NASDAQ:BIOA) STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Bi...

How might the approval impact BioArctic's revenue forecasts, partnership dynamics with Eisai, and potential reimbursement or pricing negotiations? What is the projected market share for BioArctic's lecanemab compared to existing Alzheimer’s therapies and upcoming pipeline candidates? How will the FDA approval of lecanemab subcutaneous injection affect BIOA's stock volatility and price targets in the short term?
Symbol: BIOA
Approval
18 days ago
Read more prnewswire